This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braunstein, A.
Right arrow Articles by Shai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braunstein, A.
Right arrow Articles by Shai, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2004, p. 3127-3129, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3127-3129.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vitro Activity and Potency of an Intravenously Injected Antimicrobial Peptide and Its DL Amino Acid Analog in Mice Infected with Bacteria

Amir Braunstein,{dagger} Niv Papo,{dagger} and Yechiel Shai*

Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel

Received 28 January 2004/ Returned for modification 29 February 2004/ Accepted 19 April 2004

We report that intravenous injection (3 mg/kg of body weight twice daily) of a diastereomer (containing 33% D amino acids) of an antimicrobial peptide, K6L9 (LKLLKKLLKKLLKLL-NH2), but not the all-L-amino-acid parental peptide, cures neutropenic mice infected with gentamicin-sensitive Pseudomonas aeruginosa and gentamicin-resistant Acinetobacter baumannii bacteria. Various biophysical experiments suggest a membranolytic-like effect.


* Corresponding author. Mailing address: Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, 76100 Israel. Phone: 972-8-9342711. Fax: 972-8-9344112. E-mail: Yechiel.Shai{at}weizmann.ac.il.

{dagger} A.B. and N.P. contributed equally to the paper.


Antimicrobial Agents and Chemotherapy, August 2004, p. 3127-3129, Vol. 48, No. 8
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.8.3127-3129.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Zhang, G., Han, B., Lin, X., Wu, X., Yan, H. (2008). Modification of Antimicrobial Peptide with Low Molar Mass Poly(ethylene glycol). J Biochem 144: 781-788 [Abstract] [Full Text]  
  • Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
  • Deslouches, B., Gonzalez, I. A., DeAlmeida, D., Islam, K., Steele, C., Montelaro, R. C., Mietzner, T. A. (2007). De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 60: 669-672 [Abstract] [Full Text]  
  • Rodriguez-Hernandez, M. J., Saugar, J., Docobo-Perez, F., de la Torre, B. G., Pachon-Ibanez, M. E., Garcia-Curiel, A., Fernandez-Cuenca, F., Andreu, D., Rivas, L., Pachon, J. (2006). Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 58: 95-100 [Abstract] [Full Text]  
  • Saugar, J. M., Rodriguez-Hernandez, M. J., de la Torre, B. G., Pachon-Ibanez, M. E., Fernandez-Reyes, M., Andreu, D., Pachon, J., Rivas, L. (2006). Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii: Molecular Basis for the Differential Mechanisms of Action.. Antimicrob. Agents Chemother. 50: 1251-1256 [Abstract] [Full Text]  
  • Cotter, P. D., O'Connor, P. M., Draper, L. A., Lawton, E. M., Deegan, L. H., Hill, C., Ross, R. P. (2005). Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc. Natl. Acad. Sci. USA 102: 18584-18589 [Abstract] [Full Text]